Jim Simons Applied Molecular Transport Inc. Transaction History

Renaissance Technologies LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$0.16 - $0.34 $1,424 - $3,026	8,900 Added 3.26%	282,187 $44,000
Q2 2023 Aug 11, 2023	BUY	$0.24 - $0.37 $960 - $1,480	4,000 Added 1.49%	273,287 $71,000
Q1 2023 May 12, 2023	SELL	$0.32 - $0.68 $93,252 - $198,160	-291,413 Reduced 51.97%	269,287 $86,000
Q4 2022 Feb 13, 2023	SELL	$0.35 - $1.26 $41,510 - $149,436	-118,600 Reduced 17.46%	560,700 $235,000
Q3 2022 Nov 14, 2022	BUY	$1.12 - $3.12 $164,765 - $458,989	147,112 Added 27.64%	679,300 $661,000
Q2 2022 Aug 12, 2022	BUY	$2.76 - $7.65 $287,006 - $795,508	103,988 Added 24.28%	532,188 $1.55 Million
Q1 2022 May 13, 2022	BUY	$5.63 - $13.88 $1.43 Million - $3.53 Million	254,600 Added 146.66%	428,200 $3.22 Million
Q4 2021 Feb 11, 2022	BUY	$13.23 - $26.05 $1.87 Million - $3.68 Million	141,100 Added 434.15%	173,600 $2.43 Million
Q3 2021 Nov 12, 2021	BUY	$25.87 - $46.61 $840,775 - $1.51 Million	32,500 New	32,500 $841,000

9.42K

Ticker AMTI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,900,600
Description
Applied Molecular Transport Inc., a clinical-stage biopharmaceutical company, engages in the design and development of a pipeline of oral and respiratory biologic product candidates to treat autoimmune, inflammatory, metabolic, and other diseases. The company's lead product candidate is AMT-101, a gastrointestinal (GI) selective oral fusion of r...

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.